Products

Senmind

AI-native

Read between the lines. Reply with confidence.

senmind.netlify.app Writing & Documents / AI Writing Assistants

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$4.31/mo
Lower than 94% of peersNiche median $12/mo
Creators
Olivier Labuda
No social account linked
Launched
6mo ago
2026-06-03 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Your stress-free and conmfident communication buddy

    Jun 3 · 6mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered 2018-05-08

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Premium
€3.99/month

Trial: You will get an email the moment it is ready so you can claim your 1-week free Premium trial. · Observed 2026-11-08 · Source page

Entry price $4.31/mo, Lower than 94% of peers; “AI Writing Assistants” median is $12/mo.View pricing benchmark

Website snapshots

Indexed 2026-06-03

Key pages

Desktop & mobile archive
Home
senmind.netlify.app/ Snapshot 2026-11-08

Questions & evidence

How much does Senmind cost?
Premium: €3.99/month. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Senmind get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Senmind and what platforms does it support?
Senmind is catalogued under AI Writing Assistants: Read between the lines. Reply with confidence. Supported platforms: Web.

Related products in this category

Writing & Documents / AI Writing Assistants

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.